A survey of the antibiotic treatment of febrile neutropenia in haematology units in the United Kingdom

Clinical and Laboratory Haematology

Volumn 27, Issue 6, 2005, Pages 374-378

  Ziglam, Hisham M ^a   Gelly, K J ^a   Olver, W J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adult; Antibiotic prophylaxis; Antibiotic therapy; Fever; Neutropenia

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; DRUG CHOICE; DRUG SUBSTITUTION; FEBRILE NEUTROPENIA; HEALTH SURVEY; HUMAN; MONOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DATA COLLECTION; DRUG THERAPY, COMBINATION; FEVER; GREAT BRITAIN; HEMATOLOGY; HOSPITAL UNITS; HUMANS; NEUTROPENIA; PHYSICIAN'S PRACTICE PATTERNS;

EID: 28944438746     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2005.00735.x     Document Type: Review

References (21)

1. Cruciani M., Rampazzo R., Malena M., Lazzarini L., Todeschini G., Messori A. & Concia E. (1996) Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clinical Infectious Diseases 23, 795-805.
2. El Bakri F., Pallett A., Smith A.G. & Duncombe A.S. (1998) Ototoxicity induced by once-daily gentamicin. The Lancet 351, 1407-1408.
3. Engels E.A., Lau J. & Barza M. (1998) Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. Journal of Clinical Oncology 16, 1179-1187.
4. EORTC International Antimicrobial Therapy Cooperative Group (1987) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. New England Journal of Medicine 317, 1692-1698.
5. European Organization for Research and Treatment of Cancer (EORTC), International Antimicrobial Therapy Cooperative Group & National Cancer Institute of Canada-Clinical Trials Group (1991) Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. Journal of Infectious Diseases 163, 951-958.
6. Furno P., Bucaneve G. & Del Favero A. (2002) Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet Infectious Diseases 2, 231-242.
7. Gafter-Gvili A., Fraser A., Paul M. & Leibovici L. (2005) Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Annals of Internal Medicine 142, 979-995.
8. Garcia-Rodriguez J.A., Gobernado M., Gomis M., Mensa J., Picazo J., Prieto J., Carreras E., La Camara R.D. & Sanz M.A. (2001) Clinical guide for the evaluation and treatment of patients with neutropenia and fever. Revista Espanol de Quirnioterapia 14, 75-83.
9. Hatala R., Dinh T.T. & Cook D.J. (1997) Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clinical Infectious Diseases 24, 810-815.
10. Hori S., Sunley R., Tami A. & Grundmann H. (2002) The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital. Journal of Hospital Infecion 50, 25-29.
11. Hughes W.T., Armstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., Feld R., Pizzo P.A., Rolston K.V., Shenep J.L. & Young L.S. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases 34, 730-751.
12. Kern W.V., Klose K., Jellen-Ritter A.S., Oethinger M., Bohnert J., Kern P., Reuter S., von Baum H. & Marre R. (2005) Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. European Journal of Clinical Microbiology and Infectious Diseases 24, 111-118.
13. Link H., Bohme A., Comely O.A., Hoffken K., Kellner O., Kern W.V., Mahlberg R., Maschmeyer G., Nowrousian M.R., Ostermann H., Ruhnke M., Sezer O., Schiel X., Wilhelm M. & Auner H.W. (2003) Antimicrobial therapy of unexplained fever in neutropenic patients-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Annals of Hematology 82(Suppl. 2), S105-S117.
14. Mebis J., Goossens H., Bruyneel P., Sion J.P., Meeus I., Van Droogenbroeck J., Schroyens W. & Berneman Z.N. (1998) Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients. Leukemia 12, 1627-1629.
15. Paul M., Soares-Weiser K. & Leibovici L. (2003). Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. British Medical Journal 326, 1111.
16. Paul M., Borok S., Fraser A., Vidal L. & Leibovici L. (2005) Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy 55, 436-444.
17. Rolston K.V., Berkey P., Bodey G.P., Anaissie E.J., Khardori N.M., Joshi J.H., Keating M.J., Holmes F.A., Cabanillas F.F. & Elting L. (1992) A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Archives of Internal Medicine 152, 283-291.
18. Safdar N., Handelsman J. & Maki D.G. (2004) Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infectious Diseases 4, 519-527.
19. Schimpff S.C. (1985) Overview of empiric antibiotic therapy for the febrile neutropenic patient. Reviews of Infectious Diseases 7(Suppl. 4), S734-S740.
20. Schimpff S.C., Gaya H., Klastersky J., Tattersall M.H. & Zinner S.H. (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. Journal of Infectious Diseases 137, 14-29.
21. Viscoli C. & Castagnola E. (1998) Planned progressive antimicrobial therapy in neutropenic patients. British Journal of Haematology 102, 879-888.